JNJ Stock Analysis: Johnson & Johnson
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was fou
- Latest close
- $256.03
- 20-day change
- -8.05%
- Trend state
- LEAN BULL
- Classification
- Healthcare · Drug Manufacturers - General
Market context
Johnson & Johnson moved -8.05% over the latest 20-session window. BullRecon currently classifies the broader setup as LEAN BULL.
Latest report
The latest cached company filing period (FY2025 · $94.2B revenue · $26.8B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Profitability is currently the strongest dimension at 5.6/6, while Value is the lowest at 3.6/6. Scores are comparative research signals, not forecasts.